NCT03839732

Brief Summary

BACKGROUND In the context of a progressively aging population, monitoring the status of Vascular Calcifications (VC) and Vertebral Fractures (VF) over time would be of primary importance, as VC and VF are recognized to be hallmarks of severe cardiovascular events (hospitalization and/or death) and hip fractures respectively, and VF represent an under-diagnosed cause of progressive disability and pain on its own. Moreover, there is an acknowledged relationships between VC and VF. However, data about the emergence/progression of VC and the emergence/worsening of VF over time are lacking. This is likely due to the absence of monitoring instruments for VC and VF that are both precise and easily accessible/applicable. OBJECTIVE This study aims to define the observer variability of a new software developed by the study sponsor and collaborators, called Calcify2D. Calcify2D offers physicians a computer-assisted procedure to simultaneously score vascular calcifications at the abdominal aorta and lumbar vertebral fractures (according to Quantitative Vertebral Morphometry principles) based on a latero-lateral thoracolumbar spine radiography. Secondary aims are the validation of the scores obtained from latero-lateral thoracolumbar spine radiography with more invasive and/or costly gold-standard imaging modalities (Computed Tomography for VC, Magnetic Resonance for VF) that may have been acquired near-simultaneously to radiographs on the patients enrolled for the study. STUDY DESIGN Not-for-profit monocentric observational study to be conducted on the diagnostic images of the thoracolumbar spine already collected at Istituto Ortopedico Rizzoli (IOR) within a previous interventional study. Scoring of VC and VF will be performed by four clinicians from four relevant specialties, chosen among those who may often see VC and VF and are already familiar with the traditional scoring systems for both VC and VF (one radiologist and one spine orthopaedics from IOR, one nephrologist from the National Research Council and one internist from University of Padua). Each clinician will assess all radiographs to score VC and QVM, both via computer assisted procedures and via traditional visual inspection. To avoid bias, an interval of at least one week will be left between the computer assisted and visual scoring. To define intra-observer variability (i.e. repeatability), the whole dataset will be re-assessed three times.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2021

Completed
Last Updated

May 24, 2023

Status Verified

May 1, 2023

Enrollment Period

11 months

First QC Date

February 8, 2019

Last Update Submit

May 23, 2023

Conditions

Keywords

observer variabilitykauppila scorequantitative vertebral morphometrycomputer assisted procedureabdominal aortalumbar spine

Outcome Measures

Primary Outcomes (1)

  • Observer variability in scoring Vascular Calcification at the abdominal aorta

    Observer variability (repeatability and reproducibility) in the assessment of vascular calcifications at the abdominal aorta according to a widely adopted scoring system (Kauppila et al., 1997): comparison between computer assisted and visual scoring.

    through study completion, 1 year at maximum

Secondary Outcomes (3)

  • Observer variability in scoring Vertebral Fractures at the lumbar spine

    through study completion, 1 year at maximum

  • Accuracy of computer assisted VC score

    through study completion, 1 year at maximum

  • Accuracy of computer assisted QVM

    through study completion, 1 year at maximum

Study Arms (1)

Vascular Calcification Group

Patients with prevalent vascular calcifications will be analysed to verify the intra- and inter-observer reliability of the score of abdominal aorta calcifications

Diagnostic Test: Score of abdominal aorta calcifications

Interventions

Radiographs showing VC will be used to assess whether the computer assisted VC scoring (primary objective) and Quantitative Vertebral Morphometry (QVM, limited to lumbar spine, secondary objective n.1) through the Calcify2D software are less variable with respect to the traditional visual scoring of VC and QVM.

Also known as: Score of lumbar spine vertebral fractures
Vascular Calcification Group

Eligibility Criteria

Age20 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients that were included in a previous interventional trial of the sponsor institution aimed to compare the effectiveness of vertebroplastic and kyphoplastic augmentations of the throracolumbar spine. The choice of this population was driven by previous reports on similar populations stating a high prevalence of vascular calcifications.

You may qualify if:

  • Patients included in a previous interventional study (VTP vs KYPHO) of the sponsor.
  • Availability of diagnostic images (Dorso-lumbar radiographies taken in L-L projection).
  • Rx images will be screened for the presence of VC, retaining only those showing VC.
  • Informed consent obtained prior to any study analysis-evaluation.

You may not qualify if:

  • Images showing severe artefacts (usually due to presence of metallic devices) that alter the grayscale range and hinder correct identification of VC and vertebral fractures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Ortopedico Rizzoli

Bologna, BO, 40136, Italy

Location

MeSH Terms

Conditions

Vascular CalcificationSpinal Fractures

Condition Hierarchy (Ancestors)

CalcinosisCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesSpinal InjuriesBack InjuriesWounds and InjuriesFractures, Bone

Study Officials

  • Enrico Schileo, Ph.D.

    Istituto Ortopedico Rizzoli

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 15, 2019

Study Start

November 28, 2018

Primary Completion

October 31, 2019

Study Completion

April 27, 2021

Last Updated

May 24, 2023

Record last verified: 2023-05

Locations